Mesenchymal stem cells alleviate dexamethasone-induced muscle atrophy in mice and the involvement of ERK1/2 signalling pathway

Abstract Background High dosage of dexamethasone (Dex) is an effective treatment for multiple diseases; however, it is often associated with severe side effects including muscle atrophy, resulting in higher risk of falls and poorer life quality of patients. Cell therapy with mesenchymal stem cells (...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Belle Yu-Hsuan Wang, Allen Wei-Ting Hsiao, Hoi Ting Shiu, Nicodemus Wong, Amanda Yu-Fan Wang, Chien-Wei Lee, Oscar Kuang-Sheng Lee, Wayne Yuk-Wai Lee
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-08-01
coleção:	Stem Cell Research & Therapy
Assuntos:	Mesenchymal stem cell Muscle atrophy Dexamethasone Cell therapy
Acesso em linha:	https://doi.org/10.1186/s13287-023-03418-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!